Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre StudyTiago Torres, Paolo Gisondi, Carlo Alberto Maronese et al.|American Journal of Clinical Dermatology|2024Cited by 58
Osteopontin, CCL5 and CXCL9 are independently associated with psoriasis, regardless of the presence of obesityGleison Vieira Duarte, Edgar M. Carvalho, Larissa Porto-Silva et al.|Cytokine|2015Cited by 30